Drug Profile
ASG 5ME
Alternative Names: AGS-5-ME; ASG-5-MELatest Information Update: 15 Dec 2023
Price :
$50
*
At a glance
- Originator Agensys; Seattle Genetics
- Class Antineoplastics; Auristatins; Drug conjugates; Immunoconjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gastric cancer; Pancreatic cancer; Prostate cancer